Huawei unveiled the Mate XT 2 tri-fold smartphone featuring its Kirin 9050 Pro processor, the first chip built using the company's proprietary Tau Scaling Law and LogicFolding 3D architecture. The chip claims 55% transistor density gains over the previous generation without using EUV lithography.
Xiaomi India announced continued smartphone price increases through late 2026, citing both the global chip shortage and rising costs from AI features that require more memory. The warning comes as Xiaomi and Huawei unveil new foldable phones featuring proprietary chips in competition with Apple.
Chinese President Xi Jinping will visit Egypt next week for the first time in a decade, coinciding with Huawei's bid to build AI data centers for the Egyptian government. The US State Department is countering by assembling a rival consortium including Nvidia, AMD, and Microsoft.
Nvidia announced a plan with major Wall Street firms including BlackRock, Goldman Sachs, and KKR to mobilize up to $500 billion for AI infrastructure. Analysts warn the deal faces significant risk from China's Huawei chip production surge, which could depress secondary GPU market prices that serve as collateral for the financing structure.
Insilico Medicine CEO Alex Zhavoronkov told Reuters that the company typically reaches a developmental drug candidate in 13 months, with a record of nine months, by combining AI with its research operations in China. Reuters reported that China has become a major hub for next-generation medicine development, aided by lower research costs and streamlined regulation.
US export restrictions are driving China's AI chip sector away from general-purpose GPUs toward custom ASICs, with Huawei commanding 62% projected market share. Meanwhile, Enflame Technology is preparing a $893 million Shanghai STAR Market IPO despite persistent losses and heavy reliance on Tencent.
